$139.1K – $231.9K/yr
As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines. The Health Technology Assessment (HTA), Value & Evidence (HV&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decision-making. ROLE SUMMARY The HTA, Value & Evidence Senior Manager is responsible for development and execution of high-quality HV&E strategic efforts to support optimal access and reimbursement for treatments in Oncology. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of Oncology medicines. This position will be part of Pfizer’s dynamic HTA Value & Evidence team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to the GU Cancer Portfolio. This position will be working closely with the Oncology cross-functional teams (e.g., access, medical, clinical, commercial, etc.) and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and society in general. This position will function in a closely aligned fashion with the Global Access Strategy and Pricing (GASP) team to ensure there is a single and coordinated view on strategy and project execution. This position will function with a ‘OnePfizer’ mindset and will work in a closely ali